Healthcare -
Biotechnology - NASDAQ - CA
$ 0.791
-5.66 %
$ 61 M
Market Cap
-3.16
P/E
ONCY - COST OF REVENUE
Cost of Revenue ONCY - Oncolytics Biotech Inc.
403 K
LAST VALUE
-5.58%
2 YEAR CAGR
33.41%
5 YEAR CAGR
0.00%
10 YEAR CAGR